Japan Biodefense Market Size & Outlook, 2021-2030
Japan biodefense market, 2018-2030 (US$M)
Related Markets
Japan biodefense market highlights
- The Japan biodefense market generated a revenue of USD 255.7 million in 2021 and is expected to reach USD 500.5 million by 2030.
- The Japan market is expected to grow at a CAGR of 7.7% from 2022 to 2030.
- In terms of segment, anthrax was the largest revenue generating product in 2021.
- Radiation/nuclear is the most lucrative product segment registering the fastest growth during the forecast period.
Biodefense market data book summary
| Market revenue in 2021 | USD 255.7 million |
| Market revenue in 2030 | USD 500.5 million |
| Growth rate | 7.7% (CAGR from 2021 to 2030) |
| Largest segment | Anthrax |
| Fastest growing segment | Radiation/nuclear |
| Historical data | 2018 - 2020 |
| Base year | 2021 |
| Forecast period | 2022 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Anthrax, Small Pox, Botulism, Radiation/nuclear |
| Key market players worldwide | Altimmune Inc, Emergent BioSolutions Inc, Dynavax Technologies, SIGA Technologies Inc, Elusys Therapeutics, Ichor Medical Systems, Cleveland-Cliffs Inc, Bavarian Nordic A/S, Ology Bioservices, Alnylam Pharmaceuticals Inc, XOMA |
Other key industry trends
- In terms of revenue, Japan accounted for 1.8% of the global biodefense market in 2021.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In Asia Pacific, Japan biodefense market is projected to lead the regional market in terms of revenue in 2030.
- India is the fastest growing regional market in Asia Pacific and is projected to reach USD 199.3 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Biodefense Market Scope
Biodefense Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
Japan biodefense market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to biodefense market will help companies and investors design strategic landscapes.
Anthrax was the largest segment with a revenue share of 28.16% in 2021. Horizon Databook has segmented the Japan biodefense market based on anthrax, small pox, botulism, radiation/nuclear covering the revenue growth of each sub-segment from 2018 to 2030.
Reasons to subscribe to Japan biodefense market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Japan biodefense market databook
-
Our clientele includes a mix of biodefense market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the Japan biodefense market , including forecasts for subscribers. This country databook contains high-level insights into Japan biodefense market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
Japan biodefense market size, by product, 2018-2030 (US$M)
Japan Biodefense Market Outlook Share, 2021 & 2030 (US$M)
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
